- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-Midkine
Midkine Polyclonal Antibody for WB, IP, IF, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris et plus (1)
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 11009-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | tissu embryonnaire de souris, cellules COLO 320, cellules SH-SY5Y |
Résultats positifs en IP | tissu embryonnaire de souris, |
Résultats positifs en IF/ICC | cellules HeLa, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 3 publications below |
WB | See 8 publications below |
IHC | See 2 publications below |
IF | See 5 publications below |
Informations sur le produit
11009-1-AP cible Midkine dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | Midkine Protéine recombinante Ag1465 |
Nom complet | midkine (neurite growth-promoting factor 2) |
Masse moléculaire calculée | 16 kDa |
Poids moléculaire observé | 16 kDa |
Numéro d’acquisition GenBank | BC011704 |
Symbole du gène | Midkine |
Identification du gène (NCBI) | 4192 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Midkine is a heparin-binding growth factor identified over 20 years ago and enhances the survival, migration and many other activities of target cells. Midkine is rich in both basic amino acids and cysteine, and is not related to most other growth factors/cytokines. It is strongly expressed during embryonic periods, especially at the midgestation stage, and plays important roles in development, especially in neurogenesis. Midkine expression in adult tissue is generally weak or undetectable, and it is induced upon injury and exerts many activities related to tissue repair. The biological activities of midkine in malignant tumors include proliferation, angiogenesis, invasion and metastasis. Various cancers express significantly higher levels of the midkine protein in early stage tumor tissues than in adjacent normal tissue.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for Midkine antibody 11009-1-AP | Download protocol |
IHC protocol for Midkine antibody 11009-1-AP | Download protocol |
IF protocol for Midkine antibody 11009-1-AP | Download protocol |
IP protocol for Midkine antibody 11009-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Front Immunol Roles of the m6A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell Analyses.
| ||
Front Oncol Targeting MDK Abrogates IFN-γ-Elicited Metastasis inCancers of Various Origins. | ||
Cancer Cell Int Midkine promotes glioblastoma progression via PI3K-Akt signaling.
| ||
Am J Respir Cell Mol Biol Mesenchymal Glucocorticoid Receptor Regulates Development of Multiple Cell Layers of the Mouse Lung. | ||
J Mol Neurosci Electroacupuncture Alleviated Neuronal Apoptosis Following Ischemic Stroke in Rats via Midkine and ERK/JNK/p38 Signaling Pathway. |